Contraception
Volume 76, Issue 1 , Pages 49-52 , July 2007

Chronic endometritis in DMPA users and Chlamydia trachomatis endometritis

  • Andrea Ries Thurman

      Affiliations

    • Department of OBGYN, University of Texas Health Sciences Center San Antonio, San Antonio, TX 78229-3900, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 210 467 5080; fax: +1 210 467 5080.
    • ,
  • Charles H. Livengood

      Affiliations

    • Chlamydia Testing Laboratory, Department of Obstetrics and Gynecology, Duke University, Durham, NC 27710, USA
    • ,
  • David E. Soper

      Affiliations

    • Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC 29425, USA

Received 18 September 2006 ,Revised 21 March 2007 ,Accepted 22 March 2007.

References 

  1. Speroff L, Darney PD. Long-acting methods of contraception. In:  Speroff L,  Glass RH,  Kase NG editor. Clinical gynecologic endocrinology and infertility. 6th ed.. Baltimore (MD): Lippincott Williams and Wilkins; 1999;p. 962–969
  2. Kaunitz AM. Long-acting injectable contraception with depot medroxyporgesterone acetate. Am J Obstet Gynecol. 1994;170:1543–1549
  3. Kaunitz AM. Injectable long-acting contraceptives. Clin Obstet Gynecol. 2001;44:73–91
  4. Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo Provera), or the combined oral contraceptive pill as contraception. Pediatrics. 1994;94:687–694
  5. Fraser IS. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives. Contraception. 1983;28:385–397
  6. Speroff L, Darney PD. In: A clinical guide for contraception. 3rd ed.. Philadelphia (PA): Lippincott Williams and Wilkins; 2001;p. 206–207[Chapter 6]
  7. Thurman AR, Soper DE. Endometrial histology of Depo Provera users. J Infect Dis Obstet Gynecol. 2006;69402:1–6
  8. Krettek JE, Arkin SI, Chaisilwattana P, Monif GRG. Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting. Obstet Gynecol. 1993;81:728–731
  9. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach DA, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiological associations. Am J Med. 1983;74:14–22
  10. Livengood CH, Wrenn JW. Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseriagonorrhoeae by coamplification of endocervical specimens. J Clin Microbiol. 2001;39:2928–2932
  11. Heatley MK. The association between clinical and pathological features in histologically identified chronic endometritis. J Obstet Gynaecol. 2004;24:801–803
  12. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis. 2005;32:400–405
  13. Haggerty CL, Ness RB, Amortegui A, et al. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol. 2003;188:141–148
  14. Toth M, Patton DL. Histologic assessments of endometrial biopsies indicate an association between CT and AUB. Presentation, Infectious Diseases Society for Obstetrics and Gynecology Annual Scientific Meeting and Symposium, August 19, 2005, Charleston, SC. This was an abstract presented at this meeting. This abstract has not been published. The abstract can be obtained on the IDSOG web site (http://www.IDSOG.org).
  15. Mishell DR, Kharma KM, Thorneydroft IH, Nakamura RM. Estrogenic activity in women receiving an injectable progestogen for contraception. Am J Obstet Gynecol. 1972;113:372–376
  16. Maslow AS, Davis CH, Choong J, et al. Estrogen enhances attachment of Chlamydia trachomatis to human endometrial epithelial cells in vitro. Am J Obstet Gynecol. 1988;159:1006–1014
  17. Archer DF, Philput CA, Weber ME. Management of irregular uterine bleeding and spotting associated with Norplant. Hum Reprod. 1996;11(Suppl 2):24–30
  18. Diaz S, Croxatto HB, Pavex M, Belhadj H, Stern J, Sivin I. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception. 1990;42:97–109
  19. Kaewrudee S, Taneepanichskul S, Jaisamraun U, Reinprayoon D. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use. Contraception. 1999;60:25–30
  20. Tantiwattanakul P, Taneepanichskul S. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users. Contraception. 2004;70:277–279
  21. Ferenczy A. Pathophysiology of endometrial bleeding. Maturitas. 2003;45:1–14
  22. Downie J, Ooyser NL, Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. Am J Physiol. 1974;236:465–472
  23. White JO, Sullivan MHF, Patel L, et al. Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring. Contraception. 1991;43:401–412
  24. Achilles SL, Amortegui AJ, Wiesenfeld HC. Endometrial plasma cells: do they indicate subclinical pelvic inflammatory disease?. Sex Transm Dis. 2005;32:185–188

PII: S0010-7824(07)00143-6

doi: 10.1016/j.contraception.2007.03.006

Contraception
Volume 76, Issue 1 , Pages 49-52 , July 2007

Article Tools